Verrina E, Zacchello G, Perfumo F, Edefonti A, Sorino P, Bassi S, Andreetta B, Cattarelli D, Capasso G, Consalvo G
Italian Registry of Pediatric Chronic Peritoneal Dialysis, Italy.
Adv Perit Dial. 1995;11:281-4.
Chronic peritoneal dialysis (CPD) is the first treatment modality for most infants with end-stage renal failure; this group of patients shows peculiar clinical and technical problems. We present the data from a National Registry on 22 children starting CPD under one year of age, representing 11.6% of the total population of the Registry (189 patients). Mean weight at start of CPD was 6.1 +/- 1.8 kg and duration of dialysis was 22.1 +/- 15.5 months. During the follow-up period, 9 patients were transplanted, 1 was shifted to hemodialysis, and 4 died. Patient survival was 89.1% and 82.2% at 1 and 2 years (97.9% and 96.5% in the group of 167 older children); technique survival results were 89.1% at 1 year and 77.1% at 2 years (vs 92.5% and 85.7%, respectively). The incidence of peritonitis was 1 episode every 15.6 CPD-months (1:16.1 in the older children). Catheter-related complications occurred more frequently in infants (1:11.8 vs 1:17 episode:CPD-months), even if this difference was not statistically significant. Statural growth was on average -0.29 +/- 0.66 SD/year with a significant improvement between the first (-0.50 +/- 0.79) and the second (+0.23 +/- 0.77) year of CPD. Our data confirm that infants represent a higher risk group and that they can be treated satisfactorily with CPD while awaiting renal transplantation.
慢性腹膜透析(CPD)是大多数终末期肾衰竭婴儿的首选治疗方式;这类患者存在特殊的临床和技术问题。我们展示了来自一个全国性登记处的数据,该登记处有22名一岁以下开始进行CPD的儿童,占登记处总人口(189名患者)的11.6%。开始CPD时的平均体重为6.1±1.8千克,透析时间为22.1±15.5个月。在随访期间,9名患者接受了移植,1名转为血液透析,4名死亡。1年和2年时的患者生存率分别为89.1%和82.2%(167名大龄儿童组分别为97.9%和96.5%);技术生存率1年时为89.1%,2年时为77.1%(大龄儿童组分别为92.5%和85.7%)。腹膜炎的发生率为每15.6个CPD月发生1次(大龄儿童组为1:16.1)。导管相关并发症在婴儿中更频繁发生(1:11.8对比1:17次发作:CPD月),即使这种差异无统计学意义。身高增长平均为-0.29±0.66标准差/年,在CPD的第一年(-0.50±0.79)和第二年(+0.23±0.77)之间有显著改善。我们的数据证实婴儿是一个高风险群体,并且在等待肾移植期间,他们可以通过CPD得到满意的治疗。